Articles related to Pulmonology

ICU mortality rates for Legionella pneumonia can reach up to 41.7%, with immunocompromised patients facing particularly high risk – making proper diagnosis and treatment crucial in severe cases.

“Pulmonary arterial hypertension, a rare [form] of pulmonary hypertension, has a disproportionate impact on women,” wrote investigator Vallerie V. McLaughlin, MD, and co-authors in a published abstract for the study.

Bevacizumab therapy demonstrated marked improvement in both epistaxis severity and abdominal symptoms, despite unchanged radiographic appearance of hepatic AVMs, suggesting therapeutic benefit at the microvasculature level.

The updated COVID-19 vaccines generate a more pronounced and specific immune response against current circulating strains, potentially reducing infection rates and, crucially, severe disease.

The trial found no significant difference in hospitalization or death risk between patients using long-term oxygen therapy for 24 hours versus 15 hours per day, potentially offering more freedom for those with severe hypoxemia.

Adjuvant durvalumab therapy led to a median overall survival of 55.9 months compared to 33.4 months with placebo in patients with limited-stage small-cell lung cancer who did not progress after chemoradiotherapy.